LOQTORZI 240 mg concentrate for solution for infusion
*Company:
Topalliance Biosciences Europe LimitedStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company
Updated on 12 August 2026
File name
LOQTORZI SmPC_IE_JUL2026.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.4 - Special warnings and precautions for use
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 12 August 2026
File name
LOQTORZI PIL_IE_JUL2026.pdf
Reasons for updating
- Change to section 2 - excipient warnings
- Change to section 4 - possible side effects
- Change to section 5 - how to store or dispose
- Change to section 6 - date of revision
- Change to information for healthcare professionals
File name
LOQTORZI Patient Alert Card.pdf
Reasons for updating
- Add New Doc
Free text change information supplied by the pharmaceutical company
LOQTORZI Patient Alert Card
Updated on 22 May 2026
File name
IE SPC LOQTORZI MAY 2026.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
LOQTORZI 240 mg concentrate for solution for infusion
Updated on 22 May 2026
File name
IE PIL LOQTORZI MAY 2026.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
Patient Information Leaflet - May 2026
Topalliance Biosciences Europe Limited
Address:
Ground Floor, Two Dockland Central Guild Street - I.F.S.C. Dublin 1 - Co. Dublin D01 K2C5 IrelandTelephone:
+44 7917790417Website:
https://www.topalliancebio.com/